✦ LIBER ✦

Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer

✍ Scribed by Kohn, E. C.; Sarosy, G.; Bicher, A.; Link, C.; Christian, M.; Steinberg, S. M.; Rothenberg, M.; Adamo, D. O.; Davis, P.; Ognibene, F. P.; Cunnion, R. E.; Reed, E.

Book ID: 121412290
Publisher: Oxford University Press
Year: 1994
Tongue: English
Weight: 675 KB
Volume: 86
Category: Article
ISSN: 0027-8874
DOI: 10.1093/jnci/86.1.18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary cytoreductive surgery in patie

Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis

✍ Petrillo, M.; Pedone Anchora, L.; Tortorella, L.; Fanfani, F.; Gallotta, V.; Pac 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 307 KB

High-dose 5-fluorouracil and leucovorin

High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer

✍ J. T. Kamphuis; M. C. Huider; G. J. Ras; C. A. H. Verhagen; I. Kateman; J. H. A. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 265 KB

Cycles of Dose-Intensive Chemotherapy wi

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer

✍ Mark A. Morgan; Edward A. Stadtmauer; Selina M. Luger; David L. Porter; Patricia 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Carboplatin hypersensitivity induced by

Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer

✍ Y. Watanabe; H. Nakai; H. Ueda; K. Nozaki; H. Hoshiai 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Dose intensive combination platinum and

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer

✍ Jeremy D. Shapiro; Mace L. Rothenberg; Gisele A. Sarosy; Seth M. Steinberg; Debr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c